Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

d July 2011.
  • Data on file.

  • Novartis Media RelationsMedia only:Investors only:Nicole Riley

    Richard JarvisNovartis Oncology

    Novartis CorporationP: +1 862 778 3110

    P: +1 212 830 2433Dana Kahn Cooper

    investor.relations@novartis.comP: +1 732 817 1800F: +1 732 817 1834For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis

    For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.


    '/>"/>

    SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
    2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
    3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
    4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
    5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
    6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
    7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
    8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
    9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
    10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
    11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
    (Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
    (Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
    Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
    ... (Nasdaq: PRGO ; TASE) today announced that ... calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment, a generic ... first to file on this product. Taclonex® ... treatment of psoriasis vulgaris in adults 18 years of ...
    ... NEW YORK, Feb. 22, 2011 Reportlinker.com announces ... in its catalogue: Global Pharmaceutical ... This report analyzes the worldwide ... by the following Dosage Forms: Injectables (Injections, Vials, ...
    Cached Medicine Technology:Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma 2Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma 3Reportlinker Adds Global Pharmaceutical Contract Manufacturing Industry 2
    (Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
    (Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
    (Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
    (Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
    Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
    ... is being tested against cervical cancer. Human papilloma virus ... but not everyone with the virus develops the cancer. ... and causes 300,000 deaths. If it is diagnosed and ... survival rate. // ,Doctors at Britain's Cancer ...
    ... has a similar impact on the body to the ... chronic disorders such as heart disease and diabetes, researchers ... people spend asleep per night in more developed countries ... change has been made to accommodate increased demands of ...
    ... New evidence has emerged to support claims that women who ... carried out in America found that women who regularly worked ... more likely to develop breast cancer than those who did ... for those who regularly worked nightshifts for more than three ...
    ... have irregular or very long menstrual cycles have a ... abnormalities needn't panic because the risk can be reduced ... weight control. // ,Menstrual cycles 40 days ... for some sort of underlying metabolic abnormality. "Over an ...
    ... cycling has shown a beneficial effect in treating sexual dysfunction ... sexual dysfunction in men because blood flow is restricted, in ... erection. The problem is that many of these men cannot ... for heart failure. ,Researchers in France reported on ...
    ... firm Gilead Sciences Inc. said it has received approval ... market its antiretroviral agent Viread (tenofovir disoproxil fumarate) for ... agents. ,Like Viread, such drugs work by blocking ... But Viread is the first nucleotide analogue reverse transcriptase ...
    Cached Medicine News:Health News:Deprived sleep leads to ageing 2
    Upper arm protection...
    Collars can be attach to any Pulse aprons....
    The front of this apron is tapered for maximum adjustability as needed. We can include a specially designed half-apron to be worn under the full apron for double protection in the abdomen/pelvic cav...
    Quick Release buckle apron is user friendly with large support straps crisscrossing the back allowing proper placement of the belt at your waist....
    Medicine Products: